- Report
- August 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- November 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- May 2023
- 180 Pages
Global
From €5656EUR$5,950USD£4,752GBP
Mammalian Cell Fermentation is a biotechnology process used to produce proteins, antibodies, and other molecules for therapeutic and diagnostic applications. It involves the growth of mammalian cells in a bioreactor, where they are exposed to a nutrient-rich medium and other environmental conditions that promote cell growth and production of the desired molecule. The process is highly regulated and requires specialized equipment and expertise.
Mammalian Cell Fermentation is used in the production of biologics, such as monoclonal antibodies, vaccines, and recombinant proteins. It is also used in the development of cell-based therapies, such as stem cell therapies and gene therapies. The market for mammalian cell fermentation is growing rapidly, driven by the increasing demand for biologics and cell-based therapies.
Some companies in the Mammalian Cell Fermentation market include Thermo Fisher Scientific, Merck KGaA, Lonza, Sartorius AG, and GE Healthcare. Show Less Read more